• Mashup Score: 0

    Background Despite the availability of COVID-19 vaccinations, there remains a need to investigate treatments to reduce the risk or severity of potentially fatal complications of COVID-19, such as acute respiratory distress syndrome (ARDS). This study evaluated the efficacy and safety of the transient receptor potential channel C6 (TRPC6) inhibitor, BI 764198, in reducing the risk and/or severity…

    Tweet Tweets with this article
    • TRPC6 inhibition was not effective in reducing the risk and/or severity of ARDS in patients with COVID-19 requiring non-invasive, supplemental oxygen support. https://t.co/5efa0zHRxO https://t.co/G9bXXE0xy8

  • Mashup Score: 0

    Introduction Exposure to asbestos increases the risk of lung cancer and mesothelioma. Few studies quantified the premature occurrence of these diseases in asbestos-exposed workers. Focus on premature disease onset (rate advancement or acceleration) can be useful in risk communication and for the evaluation of exposure impact. We estimated rate advancement for total mortality, lung cancer and…

    Tweet Tweets with this article
    • Rate advancement measurement for lung cancer and pleural mesothelioma in asbestos-exposed workers https://t.co/y0RJw8KTH7 https://t.co/2uVeXZWrho

  • Mashup Score: 3

    Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is rare, poorly understood, with heterogeneous characteristics resulting in difficult diagnosis. We aimed to systematically review evidence of soluble markers in peripheral blood or bronchoalveolar lavage fluid (BALF) as biomarkers in SSc-ILD. Method Five databases were screened for observational or interventional, peer-reviewed…

    Tweet Tweets with this article
    • Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses https://t.co/8rzvZDm2qf https://t.co/a4AuNzc1iB

  • Mashup Score: 0

    It is well established that undertaking regular vigorous physical activity is associated with a broad range of benefits, including for cardiac, metabolic and cognitive health. Participation in sport, however, places specific demands on the respiratory system of athletic individuals and by its very nature, necessitates heightened levels of ventilation for prolonged periods of time. Indeed,…

    Tweet Tweets with this article
    • Editorial Air athletes breathe: weighing benefits against harm. https://t.co/0YmGVxgM8n

  • Mashup Score: 0

    The COVID-19 pandemic, estimated to have caused at least 6.8 million deaths worldwide,1 highlighted the dearth of effective pharmacotherapy for acute respiratory distress syndrome (ARDS).2 The pandemic also served as a tremendous catalyst for ARDS clinical trials. Faced with an overwhelming number of critically hypoxaemic patients and limited intensive care resources, biopharmaceutical…

    Tweet Tweets with this article
    • Editorial Failure of TRPC6 inhibition to prevent COVID-19 deterioration: more questions than answers https://t.co/D5VpTejtKj @elevy323 @nualameyer